FDA device listing

Rapid Response Drugs of Abuse Multi-Drug Test Panel (Urine),Rapid Response Drugs of Abuse Test Strip (Urine)

FDA device listing 1095752652 · BTNX Inc.

Key facts

Proprietary names Rapid Response Drugs of Abuse Multi-Drug Test Panel (Urine),Rapid Response Drugs of Abuse Test Strip (Urine)
Owner/operator BTNX Inc.
Owner/operator number 9058575
Premarket submissions K121065
Product codes DIO, DJC, DKZ, DNK, JXM, LCM, LDJ
Device names DIO - Enzyme Immunoassay, Cocaine And Cocaine Metabolites, DJC - Thin Layer Chromatography, Methamphetamine, DKZ - Enzyme Immunoassay, Amphetamine, DNK - Thin Layer Chromatography, Morphine, JXM - Enzyme Immunoassay, Benzodiazepine, LCM - Enzyme Immunoassay, Phencyclidine, LDJ - Enzyme Immunoassay, Cannabinoids
Device class Class II, Unclassified
Classification regulations (21 CFR) 862.3100, 862.3170, 862.3250, 862.3610, 862.3640, 862.3870, ORCA1.LCM
Review panels Clinical Toxicology
Registered establishments BTNX Inc.
Establishment registrations 3003917514
FEI numbers 3003917514
Establishment operations Foreign Private Label Distributor, Repackager/Relabeler
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 10–99 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings